Contraindications : It should not be used in patients with a history of medullary thyroid carcinoma, MEN2, severe gastroparesis, pregnancy, or uncontrolled GI disease
With a simple daily servingit's easy to support natural detoxdigestive and metabolic wellness
The reasons cited by the FDA included concerns about immunogenicity, peptide impurity characterization challenges, and the lack of adequate safety data from human clinical trials
Retatrutide is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors under clinical evaluation for obesity and type 2 diabetes
Laura goes above and beyond to offer support
The individuals involved in the leadership of these connected entities have a documented legal history that directly relates to pharmaceutical manufacturing integrity